The concept of a cure in oncology, particularly for stage II and III colon cancer (CC), has historically suffered from ...

A new report released by the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) examines the global and ...

The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...

An expert discusses how treatment decisions must balance short-term burden with long-term benefits while avoiding protocol-driven step therapy requirements, as future comparative effectiveness trials ...